OPKO Health (OPK)
(Delayed Data from NSDQ)
$1.61 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.61 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Price, Consensus and EPS Surprise
OPK 1.61 0.00(0.00%)
Will OPK be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPK
OPKO Health (OPK) Q2 Earnings Top Estimates, Gross Margin Down
OPKO Health (OPK) Reports Q2 Loss, Lags Revenue Estimates
OPK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Surpass Estimates
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
Other News for OPK
Roth MKM says Small-Cap Value reaches key technical support, lists 14 "bullish" stocks
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
Opko Health Holds Strong Buy Rating: Financial Resilience and Strategic Growth Fuel Optimism
Buy Rating Affirmed for OPKO Health Amid Strategic Partnerships and Promising Pipeline Developments
OPKO Health Inc (OPK) Q2 2024 Earnings Call Transcript Highlights: Key Financial Moves and ...